U.S. Markets closed

KalVista Pharmaceuticals, Inc. (KALV)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
13.79+0.40 (+2.99%)
At close: 4:00PM EDT
Sign in to post a message.
  • Y
    Yahoo Finance Insights
    KalVista Pharmaceuticals is up 11.45% to 13.72
  • Y
    Yahoo Finance Insights
    KalVista Pharmaceuticals is up 12.77% to 12.89
  • M
    M T
    looking at the chart, this leg will go to at least $19. 00 to $19.50 before any kind of pull back. After that I can practically guarantee you a buyout for at least $25
  • E
    Ernesto
    In the coming months, this stock is expected to rise over 110%, so I am very excited to see what happens next
  • I
    Info
    Why is KALV so slow in movement. Any Idea. It has started moving since yesterday. Not much though.
    Is there some news expected??
  • M
    M T
    "Stock goes to around $19 before sell off. Then buyout around $25" That's still my prediction
  • J
    James
    At the annual meeting these questions need to be answered. Why the (insiders) CEO,CFO,Chief Scientific officer,Chief Development officer all sold stock in April at its high and have not purchased any.?. Why administrative expenses increased significantly last year? At what point did Merck stop meeting with the company and do they still have interest? Transparency, not if you contact corporate communications.
  • S
    Stuart
    This stock is toxic. Do not listen to Zack's (strong buy recommendation) or MarketWatch. When you see the executive team start to purchase shares on the open market may be then take a small position. Look at the number of shares they dumped when the stock was in the high $20s back in the spring. Unbelievable. Couple that with the mid size boutiques who play this stock like a banjo, you just cannot trust this company/stock for investment. Far too easily manipulated. Don't put your hard earned money here. Far better opportunities out there for you.
  • J
    James
    Time for the board to remove the overpaid CEO, CFO,& chief Scientific officer. The board needs to support the company by investing in the stock or resign. They should also make sure their D & O coverage is adequate.
    20% drop in 2 days, where is the SEC?
  • J
    James
    Insiders sold when the stock was high, when are they going to buy? Their lack of commitment in the last 6 months says a lot.
  • P
    Pmp613
    20% drop and no comments, crying, or groans???
  • T
    Tom
    They only thing to watch now is the burn rate and cash on hand! This two numbers will drive worsen and drive stock down to 2-3$. Especially with the news their is a better drug coming from another company.
  • Y
    Yahoo Finance Insights
    KalVista Pharmaceuticals is up 13.20% to 11.49
  • C
    CoolG
    Nice move!
  • S
    Stuart
    Market Makers trying to generate some interest in KALV by selling shares among them selves. Run it up for no reason, and then drop it for (again) no reason. This stock will run when it has real news to share. Until then . . . . waiting game. GLTL
  • I
    Info
    Any news why KALV is up today with low volume??
  • S
    Stuart
    When the market rallies, KALV goes up, but can't hold the gain.

    When the market tanks, KALV tanks with it.

    They are going to take it down some more. It's now a POS
  • M
    M T
    MASSIVE INSIDER BUYS! Has anybody even noticed the MASSIVE Insider buys at 17 bucks recently? Huge amounts bought... 1,000,000 and over. Nobody's talking about it and I'm surprised because it shows a huge amount of support from insiders and directors. These are not small buys..From Nasdaq: "As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy - they expect to make money. So let's look at two noteworthy recent insider buys.

    At KalVista Pharmaceuticals ( KALV ), a filing with the SEC revealed that on Monday, Director Albert Cha purchased 1,058,824 shares of KALV, at a cost of $17.00 each, for a total investment of $18.00M. Bargain hunters are able to pick up KALV at a price even lower than Cha did, with shares trading as low as $16.34 in trading on Thursday which is 3.9% under Cha's purchase price. KalVista Pharmaceuticals is trading up about 2.4% on the day Thursday. This buy marks the first one filed by Cha in the past twelve months. ...https://www.nasdaq.com/article/thursday-913-insider-buying-report-kalv-rigl-cm1022386
    As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy - they expect to make money. So let's.
    As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy - they expect to make money. So let's.
    www.nasdaq.com
  • S
    Stuart
    M T - I was wrong on this stock. It's been on an incredible run. When I saw the secondary, I thought this will set the stock back. Wrong again there -. GLTAL